The conference welcomes world renowned thought-leaders and nationally recognized keynote speakers each year for the Summit's general session. With notable past keynote speakers such as President George W. Bush, Michael J. Fox, Governor Mitt Romney, Dennis Miller, Steve Wynn, Bret Baier and Rob Lowe; the Summit has proven to be “the must attend” event for all healthcare professionals.
More than 125 industry executives representing leading specialty pharmacies, pharma/biotech manufacturers, managed care organizations and other healthcare stakeholders share insight and updates about key trends impacting the specialty pharmacy segment.
Attendees have the opportunity to attend clinically-focused seminars where they can achieve live continuing education credits to help advance their professional knowledge of key therapeutic categories and advancements.
Associate ProfessorUniversity of Kentucky
Patient Education and Resources Manager Amber Pharmacy
Kris Admire is a Board Certified Case Manager. She is a graduate of the University of Northern Iowa and has over 20 years of professional healthcare experience in oncology and physical medicine and rehabilitation. In her current role, Kris manages the patient education program at Amber Pharmacy. Specifically, this includes identifying and incorporating patient education, counseling and case management services to support patients and caregivers receiving medication and care through Amber Pharmacy.
Michael Agostino is the President of Amber Pharmacy, an independent provider of specialized pharmacy services nationwide, and Hy-Vee Pharmacy Solutions, an innovative joint venture between Amber Pharmacy and Hy-Vee, Inc. He is the president-elect of the National Association of Specialty Pharmacy and instructs at the University of Nebraska Medical Center’s pharmacy program. Michael is also a regular speaker and participant at national pharmacy conferences.
Vice President of PBM ServicesPinnacle Rx Solutions
Dr. Don Anderson is the Vice President of Pharmacy Benefit Management at PinnacleRx Solutions in Southern California. Don has over 15 years of experience in pharmacy benefit services and clinical patient management in both private payer and managed care markets. He has successfully created specialized service provisions for high risk populations focusing on oncology, immune illness, infectious disease and micro strategies for rare diseases. Dr. Anderson is an academic preceptor for his alma mater, University of the Pacific, where he obtained his doctorate, and is also an AMCP Diplomat.
Director of Pharmacy Services, Managed CareDenver Health Medical Plan, Inc.
Michelle Beozzo Anderson is the Director of Pharmacy for Denver Health Medical Plan, Inc. (DHMP), the Managed Care division of Denver Health and Hospital Authority. She is responsible for all aspects of the pharmacy program related to the plan’s Medicare, Medicaid, Commercial, Child Health Plan Plus, and Marketplace lines of business. As part of an integrated system, her team also works closely with the health system’s 340B pharmacies.
Under Michelle’s leadership, Denver Health Medical Plan received the 2015 Quality Improvement Award from the Pharmacy Quality Alliance. The award is in recognition of achieving the largest net improvement in Part D Star Ratings of all Medicare Advantage Prescription Drug plans nationwide.
Michelle is the Managed Care delegate for the Colorado Pharmacists Society Board of Directors, as well as a member of the Academy of Managed Care Pharmacy. She completed a Managed Care Pharmacy Residency with the University of Massachusetts Medical School, Clinical Pharmacy Services and received her Doctor of Pharmacy degree from the University of Rhode Island.
Executive DirectorNational Association of Specialty Pharmacy
Sheila Arquette, Executive Director of the NASP holds a BPharm from SUNY at Buffalo. She was also the Director of Pharmacy Services for Independent Health. With extensive practical and leadership experience in retail and hospital pharmacy, Sheila’s a regular speaker at national pharmacy conferences, and industry meetings, she’s
served on the NASP membership committee and as co-chair of the Government Affairs Committee. She received the NASP Distinguished Service Award in September 2016.
PharmacistUniversity of Kentucky
Director, Center for Health Policy and Outcomes,
Memorial Sloan Kettering Cancer Center
Peter B. Bach, Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, is a physician, epidemiologist, researcher, and respected healthcare policy expert whose work focuses on the cost and value of anticancer drugs. Dr. Bach is leading efforts to increase understanding of the US drug development process and develop new models for drug pricing that include value to patients as a critical component. As the cost of specialty drugs continues to grow, he argues that prices are no longer rational, and a better pricing system could increase patient access to life-saving medications at lower costs while spurring innovation.
Sr. Vice PresidentAIM Specialty Health
National Account Executive, Health Plan & PBM, Corporate & Government ClientsBayer Healthcare Pharmaceuticals
Vice President and General Manager, U.S. Value and AccessAmgen
Global President & General Manager, Oncology,Pfizer
Liz Barrett is Global President and General Manager for Pfizer Oncology. Liz joined Pfizer in 2009 as President of the U.S. Oncology Business Unit and has since held a number of senior positions spanning Europe and North America.
Before assuming her current position, Liz was President, Europe for the Global Innovative Pharma Business and Chair of Pfizer’s European Management Team and previously, President of the Specialty Care Business, North America. Before joining Pfizer, Liz held the position of Vice-President & General Manager, Oncology Business Unit at Cephalon, Inc., where she successfully led an integrated business unit and launched the company into oncology.
Her previous experiences include managing Johnson & Johnson’s cancer therapeutics business, leading Worldwide Sales & Marketing for Veridex, LLC, a cancer diagnostics division of J&J and Vice President, Critical Care/Surgery Franchise for Ortho Biotech, another division of Johnson & Johnson. Barrett spent the first 13 years of her career in consumer packaged goods holding multiple positions in sales, sales management and marketing.
Liz has been recognized on numerous occasions for her innovation and creativity as well as leadership both internally and externally including TWIN (Tribute to Women in Industry), Marketer of the Year & HBA Rising Star. She holds a Bachelor of Science in Business Administration from the University of Louisiana and a Master’s of Business Administration in Marketing from St. Joseph’s University in Philadelphia, Pennsylvania.
Liz lives in New Hope, PA and is married with three children.
National Public Health Clinical PharmacistDepartment of Veterans Affairs
Executive Vice President, Product & StrategyOrion Health
Senior PrincipalBlue Fin Group
RHB Technical Advising
Director, Pharmacy Market SegmentURAC
Heather Bonome, URAC director of pharmacy, is responsible for the development and management of URAC’s Pharmacy Quality Management® accreditation programs. She oversees the independent advisory groups and governance committees that assist URAC in defining best practices and quality standards. She also trains and leads URAC’s pharmacist reviewers. Prior to URAC, Bonome worked in the pharmacy benefit management field for nearly 15 years, partnering with clients to develop sound clinical strategies and promote appropriate pharmaceutical utilization. Bonome received her Doctor of Pharmacy from the University of Pittsburgh, and completed a post-graduate pharmacy residency in managed care.
Vice President of Pharmacy ServicesCancer Treatment Centers of America
Vice PresidentAvalere Health
Clinical Associate Professor Rutgers University Ernest Mario School of Pharmacy
Dr. Brunetti received a Bachelor of Science degree in Biology from Saint Peter’s College in 2000. While managing a medication adherence program developed by University Research Associates in Englewood Cliffs, New Jersey, he became deeply interested in pharmacotherapy. Based on this experience, Dr. Brunetti enrolled at the Philadelphia College of Pharmacy, where he completed the Doctor of Pharmacy program in 2006. Subsequently, he completed a specialized residency in Drug Information Practice at Robert Wood Johnson University Hospital. In 2012, Dr. Brunetti completed a Master in Public Health degree with a concentration in epidemiology at the School of Public Health, Rutgers University (formerly the University of Medicine and Dentistry of New Jersey). Dr. Brunetti is a Board Certified Pharmacotherapy Specialist and a Certified Geriatric Pharmacist.
Dr. Brunetti serves as a preceptor for both Internal Medicine and Anticoagulation Advanced Pharmacy Practice Experiential (APPE) learning clerkships for Rutgers pharmacy students. He lectures in several courses ranging in content from men’s health to neurologic disease. He also serves as a lecturer for the Graduate Nutrition Program at Rutgers University. In addition, Dr. Brunetti is an active lecturer in continuing education programs directed towards pharmacists, physicians, and nurses.
Robert Wood Johnson University Hospital Somerset awarded Dr. Brunetti with the 2011 Family Medicine Teacher of the Year Award and the 2012 Friend of Nursing Award. These awards illustrate his dedication to collaborative work and breaking down barriers to improve patient care.
Vice President, Manufacturer RelationsAsembia
Chief Operating OfficerApothecary by Design
Denali Cahoon, Pharm.D., CSP, is Apothecary By Design’s chief operating officer, a role in which she guides all clinical operations and disease state programming. Since joining ABD in 2010, she also has served as pharmacist in charge, compounding manager, and a clinical pharmacist.
Beyond her work at ABD, Denali is a dedicated educator of pharmacy students. She teaches as an adjunct faculty member at the University of New England College of Pharmacy, and directs the experiential education and residency programs for ABD. In addition, she is a certified specialty pharmacist and a certified hepatitis C educator.
Denali earned her doctorate from the Massachusetts College of Pharmacy and Health Sciences, and holds a bachelor’s degree in marketing and management from Georgetown University. She is currently completing a master’s in public health at the University of New England.
Managing PartnerBlue Fin Group
Rich is an Information Services professional with a unique blend of business acumen, technical expertise, and financial acuity which enables rapid transformation of complex business needs into long-term strategic solutions. Rich is a prominent industry leader with both broad and deep knowledge and experience within managed markets, commercial operations and systems integration. He is a recognized early adopter and Pharmaceutical industry award winning team leader in the areas related to EDI, eCommerce, and Internet/Intranet technology. Rich is an Editorial Advisory Board member for Pharmaceutical Commerce Magazine and a Gerson Lehrman Group Healthcare Council Educator as well as a Gartner “Healthcare Supply Chain 25” peer voter.
Chief Pharmacy Officer,Aids Healthcare Foundation
Scott Carruthers, Pharm. D. is a Senior Manager and the Chief Pharmacy Officer at AIDS Healthcare Foundation.
As the Chief Pharmacy Officer, his responsibilities include the oversight and operation of the domestic AHF Pharmacies nationwide, including new startups and acquisitions such as the MOMS Pharmacies. Currently, there are 41 AHF Pharmacies which include the acquisition of MOMS and an additional privately owned and operated pharmacy in Ohio with over 400 employees.
Scott’s Senior Management duties included an appointment as the “Authorizing Official” for the 340B programs that cover 39 HIV specialty clinics and several STD testing sites in 14 states.
He serves on several AHF committees such as the Pharmacy and Therapeutics Committee, Quality Management Committee, Compliance Committee and chairs the Pharmacy Executive Committee.
Vice President, Specialty ProgramsConnectiveRx
Ticia is an integral part of the ConnectiveRx commitment to innovation in specialty pharmacy. She is frequently acknowledged by clients/co-workers for her in-depth knowledge of biologics honed during her tenure at Genzyme and UCB. Ticia has driven sustainable performance and cultural change to benchmark levels in the specialty market sector.
Ms. Cawley earned her BS from Northwestern University in Evanston, IL, and her BSN from Salem State College in Salem, MA. She received the Genzyme Global Marketing Vice President’s Award in 2001. She was honored in 2012 as an industry Rising Star by HBA.
Chief Executive OfficerTrio Health
Brent Clough co-founded Trio Health in 2013. Trio Health provides MFRs with real-time insight on real-world patients along with auditing the performance of physicians and pharmacies. Prior to Trio Health, Brent founded IntrinsiQ Financial in 2004, which merged with IntrinsiQ Research in 2006. IntrinsiQ developed a robust Oncology platform to allow MFRs and hedge funds to understand usage by stage, line and disease that reconciled to reported drug revenue. Upon the merger, Brent was elected President and CEO of the company. The company grew from a start-up to 90 employees prior to being acquired by Amerisource Bergen.
Before entering the healthcare industry, Brent spent eight years as a Vice President at Goldman Sachs (1996-2004) working in the investment research and equities division. Prior to Goldman, Brent worked at First Call Corporation (1988-1996) within the institutional sales and broker dealer division.
Chief Strategy OfficerAsembia
Thomas Cohn is Chief Strategy Officer for Asembia in Florham Park, New Jersey. In this role, he provides an intrinsic knowledge of the healthcare industry and innovative thinking and application development. With more than two decades of healthcare experience, Thomas has designed and implemented software systems to better manage business operations and reporting.
Before joining Asembia, Thomas held positions at CompuPharm/NeighborCare, Neuman Wholesale Drug, and Managed Health Care Associates, where he successfully developed software systems and web tools for patient billing, auditing, inventory control, and patient care programs.
Thomas received his bachelor’s degree in computer and political science from Rutgers University in New Brunswick, New Jersey and a master’s degree in computer science from the New Jersey Institute of Technology in Newark, New Jersey.
Executive Vice PresidentACTIVATE Market Access
Charles (Chuck) Collins, MS, MBA, is Executive Vice President, ACTIVATE-Market Access, a managed market consultancy focusing on the healthcare delivery disparities across multiple therapeutic areas such as oncology, rheumatoid arthritis, multiple sclerosis, diabetes, obesity, anaphylaxis prevention, osteoporosis, vaccines, Alzheimer’s disease, and chronic non-cancer pain. With a deep industry network, ACTIVATE-Market Access works across all managed market channels with particular emphasis on IDNs, ACOs, and specialty pharmacy to develop customized managed market solutions for our clients. Mr. Collins has over 25 years of career experience in the pharmaceutical industry and brings a vision of multidisciplinary expertise and stakeholder alignment to the organization. Mr. Collins also serves as a Senior Fellow to Medonomics, a nonprofit, nonpartisan think tank specializing in health policy, finance, and operations. Mr. Collins graduated with a bachelor’s degree in chemistry from Virginia Commonwealth University. Mr. Collins additionally holds a master’s degree in clinical chemistry from Old Dominion University and a master’s degree of business administration in pharmaceutical marketing from Saint Joseph’s University in Philadelphia.
Managing DirectorDeloitte Consulting LLP.
Joseph is a Managing Director in the Life Sciences Commercial Strategy & Operations Practice of Deloitte Consulting LLP. He is the leader of the Commercial Operations Transformation practice as well as the Contracting Strategy/Operations and Gross-to-Net Optimization practice. He has more than 28 years of operational and technology strategy consulting experience; 24 of them serving the Life Sciences industry; primarily in the commercial, distribution, pricing, contracting, and general council functions. During his career, he has led many large-scale systems integration projects at leading life sciences companies.
Vice President of Business DevelopmentAcro Pharmaceutical Services
Dave Coury is Vice President of Business Development at Acro Pharmaceutical Services. Involved in proactively prospecting for synergistic business opportunities between Acro’s current and potential future customers and providing advisement in implementing new business initiatives. Previous to ACRO, Dr. Coury worked as a Medical Science Liaison for Jerini US, a biotech company that specialized in peptide based medications. Prior to working for Jerini US, Dr. Coury was employed 8 ½ years at PerformRx serving in his last position as the Manager of Injectable Drug Clinical Programs and was responsible for creating specialty drug prior authorization protocols, managing the PBM’s specialty drug formulary, setting up claims and prior authorization processes and training pharmacist in specialty medication prior authorization services. Other positions included working 4 years as a clinical hospital pharmacist at 3 different hospitals and performed long-term care pharmacy consulting services from 1994 to 1997.
He is earned his Doctorate of Pharmacy degree from Temple University School of Pharmacy; Bachelor Degree in Pharmacy from Philadelphia College of Pharmacy and Bachelor Degree in Bio-chemistry from Alvernia College.
Vice President, Payer RelationsElwyn Pharmacy Group
Senior Manager of Clinical ServicesDiplomat
Dr. Crowe earned his Doctor of Pharmacy from Ferris State University (FSU) in 2009. In 2010, he completed an ASHP-accredited pharmacy residency program at Diplomat Specialty Pharmacy in Grand Rapids, Michigan, and then joined Diplomat at its corporate headquarters in Flint, Michigan. He has held roles as Clinical Program Coordinator, Clinical Technology Manager, and today works as the Senior Manager of Clinical Services. Prior to joining Diplomat, Dr. Crowe worked for five years in community pharmacy and two years as a college instructor for a pharmacy technician course. In 2013, he earned his Master of Business Administration degree from the University of Michigan-Flint and the Certified Specialty Pharmacist designation from the Specialty Pharmacy Certification Board.
Currently, Dr. Crowe serves as Adjunct Assistant Professor of Clinical Pharmacy for FSU, overseeing pharmacy interns and residents at Diplomat in Clinical Services, Industry Relations, and Professional Development learning experiences. He has presented to several health care professionals and patient support groups on a variety of topics, including specialty pharmacy, medication adherence, rheumatoid arthritis, hepatitis C, and HIV/AIDS. Dr. Crowe has also published articles in Pharmacy Today, Pharmacy Times, and Michigan Pharmacist.
Dr. Crowe has been an active member of the Michigan Pharmacists Association (MPA) and the American Pharmacists Association since 2004. In 2011, he served as chairman of the MPA’s Patient Safety Task Force and founded the Genesee County Pharmacists Association. Dr. Crowe is past chairman of MPA’s Local Association Development Committee and Secretary of the FSU College of Pharmacy Alumni Advisory Board. In 2012, Dr. Crowe earned MPA’s Distinguished New Pharmacist Practitioner Award and in 2013 received MPA’s Fellow of Michigan Pharmacists Association designation as well as the Hank Fuhs Good Government Award. He has served on the MPA Executive Board since 2014, where he is currently Speaker of the MPA House of Delegates.
Dr. Crowe lives in Grand Blanc with his wife, Erica. Together, they like to work on home improvement projects, golf, and play soccer.
President & Chief Executive OfficerCSI Specialty Group
As a thought leader, industry expert, frequent media contributor and sought after speaker on all things Specialty; Suzette’s strategic insight on marketplace trends help align and enlighten this continually pivoting industry.
Under Suzette’s leadership, CSI Specialty Group has become known as the industry’s preeminent Specialty Pharmacy Leadership Consulting firm; offering strategic solutions to all healthcare market channels across the spectrum from health systems to manufacturers, and was honored as one of Consulting Magazine's Fastest Growing Firms, ranking 5th out of 50 firms.
Suzette's passion for patient care is at the forefront in all programs CSI Specialty Group develops to support their client’s endeavors to improve patient lives, every day. She has been instrumental in positioning CSI as a leading, free resource for educational programs, as well as starting the industry's first podcast dedicated to specialty pharmacy, which focuses on enlightening trends, highlighting leaders in the industry and uncovering ways to make the specialty pharmacy journey more successful for patients worldwide.
These attributes have granted rewards from other industry leaders, as Suzette delights in providing insight, education and mentorship, while still possessing an incredible voracity for learning herself. All she learns she passes forward, which has afforded her the title of “ Queen of Specialty Pharmacy,” offered by the American Pharmaceutical Purchasing Alliance, in addition to being named a Goldman Sach’s “Top Growing Businesses” and also honored as one of Florida’s most successful Women Owned Businesses.
Suzette and her husband call the heart of specialty pharmacy home, located in Central Florida, and they are proud parents of a West Point Class of 2019 cadet.
Executive Vice President, Market and Product DevelopmentConnectiveRx
Partner, National Pharmacy Practice LeadMercer Health & Benefits
Vice President & General Manager of Specialty Pharmacy Solutions,McKesson Specialty Health
Dan Duffy leads McKesson Specialty Health’s specialty pharmacy solutions platform including the Biologics Oncology, Patient Assistance, Multi-Specialty and Clinical Research pharmacies. His responsibilities include leading the provider relations, operations, strategic planning process and developing innovative channel strategies to enhance patient care and drug access with manufacturer partners. In addition to his healthcare experience, Dan has served in a variety of industries and held management leadership roles in corporate finance, business development, and mergers and acquisitions. He also serves on the Board of Advisors for the Duke Eye Center of the Duke University Health System and is Chairman of the Board of Directors at the North Carolina Institute on Blindness.
Chief Innovation OfficerMaxor National Pharmacy Services
Associate Vice President, Strategy and InnovationGeisinger Medical Center
Managing DirectorCumberland Consulting Group
Sr. Director, Oncology Disease StateWalgreens Specialty Pharmacy
Chief Executive OfficerDrug Channels Institute
Adam J. Fein, Ph.D., is the president of Pembroke Consulting, Inc., a management advisory and business research firm based in Philadelphia. He also is the CEO of Pembroke’s Drug Channels Institute, a leading management educator for and about the pharmaceutical industry.
Dr. Fein is one of the country’s foremost experts on pharmaceutical economics and the drug distribution system. Top manufacturers call on Dr. Fein’s insights and judgment to create successful commercial strategies and make better strategic decisions in our evolving healthcare environment.
Dr. Fein’s popular and influential Drug Channels website (DrugChannels.net) is the go-to source for definitive and comprehensive industry analysis, delivered with a witty edge. He has published hundreds of academic and industry articles, and is regularly quoted in such national publications as The Wall Street Journal, The New York Times, Fortune, Drug Benefit News, and many others.
Dr. Fein earned his doctoral degree from the Wharton School of Business at the University of Pennsylvania and a B.A., summa cum laude, from Brandeis University. He lives in Philadelphia with his wife, Paula, and their two children.
VP & Chief Medical OfficerCardinal Health Specialty Solutions
Principal, Healthcare Management ConsultantMilliman
Sr. Vice PresidentPrecision for Value
Sr. Medical DirectorPriority Health
Vice President Apogenics
Sr. Vice President, Chief Medical OfficerPrime Therapeutics
PresidentSpecialty Pharmacy Certification Board
Vice President of Quality & Education PANTHERx Specialty Pharmacy
Dr. Douglas Gebhard, Pharm.D., MBA, serves as the Vice President of Quality & Education for PANTHERx™ Specialty Pharmacy. In this role he is responsible for ensuring compliance with all federal, state, and other regulatory and accrediting agencies as well as overseeing various strategic quality improvement initiatives through his role as Chair of the Quality Management Committee.
In addition to ensuring the highest standards of quality and compliance, Douglas leads a team responsible for the development and management of all clinical and education related services that support the disease management of patients, professional development of internal colleagues, and ongoing education of external stakeholders. Serving as the Chair of the Clinical Oversight Committee, Douglas is able to play a key role in the management of PANTHERx’s clinical services aimed at improving patient outcomes through improved medication adherence.
Dr. Gebhard graduated from the University of Pittsburgh School of pharmacy with his Doctor of Pharmacy degree. Additionally, he received his Masters of Business Administration from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh.
Vice President, Specialty Pharmacy ServicesValueCentric
General Session Emcee & Moderator
President & CEOURAC
Kylanne Green is president and CEO of URAC, a nonprofit organization promoting quality through accreditation, certification, and measurement. Under Green’s leadership, URAC’s accreditation became recognized as the gold standard in the pharmacy industry. Green served on URAC’s Board of Directors for two decades, and as Board Chairman for two years. Prior to joining URAC, Green was executive vice president at INOVA, the largest integrated health system in Northern Virginia, and CEO of its Care Management and Health Plan Operations. A highly respected, renowned speaker in the industry, Green shares her insights on advancing healthcare innovation and improving quality.
President, Managing PartnerPeregrine Market Access
Senior Director, Trade RelationsAsembia
Jon Haas is the Senior Director, Trade Relations for Asembia, providing HUB services, commercialization strategies and managed network solutions to manufacturing partners along with support programs to specialty pharmacy members. Jon has been in the pharmaceutical industry for over 30 years and is well versed in market and patient access solutions, specialty distribution and patient/provider support programs. Jon has previously developed and lead market access and payer focused initiatives for specialty pharmaceutical manufacturers, and has worked with many manufacturers to develop access support programs while working for specialty providers, manufacturers and consultants.
Managing PartnerGeneration Partners
Andrew Hertzmark is a Managing Partner at Generation Partners. Mr. Hertzmark operates out of the firm’s Greenwich office.
Prior to joining Generation in 2004, Mr. Hertzmark was an Associate at Galen Partners, a private equity firm focused on growth equity investments in the healthcare industry. At Galen, Mr. Hertzmark focused his time primarily on the healthcare services and information technology industries.
Mr. Hertzmark also was an Analyst and Associate in the Investment Banking divisions of Dillon, Read & Co and UBS AG, respectively, where he worked on a variety of mergers, acquisitions and capital raising assignments for companies in the healthcare sector. Additionally, Mr. Hertzmark worked in the Business Development Group at Pfizer, Inc. as well as the National Economic Council within the Executive Office of the President.
Mr. Hertzmark earned a Bachelor of Arts in Economics and Political Science from the University of Pennsylvania and an MBA from The Wharton School of Business. Mr. Hertzmark has served on the Boards of Captivate Network, Post Education, ReCept Pharmacy, ShopWiki and Virtual Radiologic Corporation. He is also involved in the firm’s investment in Donuts and ZirMed. Mr. Hertzmark currently serves as Chairman of the Board of The Wholesome Wave Foundation and is a former Board Member of The New York League for Early Learning.
Chair, Specialty Pharmacy & Pharmaceutical Practice GroupBass, Berry & Sims
Professor of Clinical Ophthalmology and Visual SciencesWashington University School of Medicine in St Louis
Nancy M. Holekamp, MD, is Professor of Clinical Ophthalmology and Visual Sciences at Washington University School of Medicine in St Louis, Missouri, and Director of Retina Services at Pepose Vision Institute in Chesterfield, Missouri. She received her medical degree from the Johns Hopkins University School of Medicine in Baltimore, Maryland. She completed her internship and residency at Washington University School of Medicine followed by her fellowship at Retina Consultants, Ltd, in St Louis.
Dr Holekamp is actively involved in clinical research, having been principal investigator or sub-investigator on more than 25 national clinical trials investigating therapies for age-related macular degeneration, retinal vascular occlusion, and diabetic retinopathy. Her efforts in research have resulted in 70 peer-reviewed publications, 21 book chapters, and more than 100 speaking invitations both nationally and internationally. She is a member of the major subspecialty societies, including the Retina Society and the Macula Society, as well as the co-founder of Women in Retina. Dr Holekamp is on the editorial board of the American Journal of Ophthalmology and also currently serves as a reviewer for several ophthalmology journals, such as Archives of Ophthalmology, Ophthalmology, and Retina. After 6 years of serving on the American Academy of Ophthalmology Ethics Committee, she has also developed an interest in medical ethics. In addition, she is recipient of several honors including the Senior Honor Award and Secretariat Award, both awarded by the American Academy of Ophthalmology in 2007, and has been named the America’s Best Doctors list since 2005.
Global Market and Business Development ManagerSonoco ThermoSafe
Marianne Hoonakker-Kelly is the Global Market and Business Development Manager for Sonoco ThermoSafe. For the last 5-years, she has been involved with the specialty pharmacy and last mile markets leading the development efforts of packaging that address the tradeoffs of performance and economics. Marianne also holds responsibility for product strategy, product development, and life cycle managementfor ThermoSafe’s specialty markets. She additionally has supported the development of sustainable, reusable solutions further up the supply chain and published “Blue is the New Green”, a white paper co-written with one of the industry’s leading wholesalers.
Marianne holds a Marketing Management degree from the University of Portland and a MBA from St. Mary’s College of California.
PresidentPharmaceutical Strategies Group
Assistant General Counsel, Pricing Reimbursement and AccessEli Lilly & Company
Past Senior Director, Commercial Excellence and OperationsBiogen
Dominique is an expert in Bio/Pharma commercial operations with a focus on commercial data enablement. Most recently at Biogen as Senior Director in Commercial Operations she led the aggregation of specialty pharmacy data for the multiple sclerosis and hematology franchises, unifying the information and its use across the enterprise. She also led key initiatives on measurement and reporting strategy to support a better understanding of patient and physician needs for both mature and launch brands. Prior to Biogen, she led the information strategy, technology and commercial operations set up for Ironwood Pharmaceuticals in advance of their first commercial launch, Linzess.
Dominique also spent time on the supplier side of the industry serving as VPGM of Epsilon (ADS) pharmaceutical practice, where she led the strategy, analytics, and technical operations for enterprise omni-channel engagements for AstraZeneca, Boehringer Ingelheim, and Procter & Gamble. Her background prior to Epsilon includes leadership roles in technology companies serving the pharmaceutical industry where her understanding of the technical and business dynamics surrounding patient, payer, and physician data helped her secure rapid growth and scale for these organizations. She is a graduate of Lehigh University College of Business and Economics and resides in the Boston area.
Chief Executive OfficerAsembia
Lawrence Irene, RPh, is co-founder and Chief Executive Officer of Asembia (Formerly Armada Health Care) in Florham Park, New Jersey. Under his leadership, Asembia has pioneered a host of unique and innovative programs to meet the needs of specialty pharmacy members, pharma/biotech manufacturer partners and other industry stakeholders, Originally founded in 2004 as Armada Health Care, Asembia focuses on the specialty pharmacy segment and offers comprehensive hub services, pharmacy network management, group purchasing (GPO) services, innovative technology platforms and more. Lawrence has more than 25 years of experience in the healthcare industry. Prior to Asembia, Lawrence co-founded and was Chief Executive Officer of Managed Healthcare Associates (MHA). Lawrence is a member of the board of directors for the National Association of Specialty Pharmacy (NASP) and a member of the advisory board for the School of Pharmacy and Health Sciences at his alma mater, St. John’s University.
Director, Market Access Operations Flexion Therapeutics
Sr. Vice President, Scientific Consulting PracticeXcenda
Jay Jackson, PharmD, MPH, is Senior Vice President of the Scientific Consulting practice at Xcenda. He leads an international team of 130+ associates specializing in global health economics, real-world evidence, outcomes research, and market intelligence to demonstrate product value and drive market access. Dr. Jackson received his Doctor of Pharmacy from the Mercer University Southern School of Pharmacy. His postdoctoral training includes the completion of an Outcomes Research Fellowship at Mercer University Southern School of Pharmacy and Applied Health Outcomes. Dr. Jackson also received a Masters of Public Health in Epidemiology from the University of South Florida College of Public Health. He currently serves as adjunct faculty for University of South Florida College of Public Health.
President & CEOOnco360 Oncology Pharmacy
Paul Jardina joined Onco360 in October of 2014 as President and Chief Executive Officer. In this role, he has overall responsibility for the strategic direction of the Company and execution of its plans.
Paul is a veteran of twenty years in the healthcare industry, with the majority of that time being dedicated to oncology. Prior to joining Onco360, Paul served as President and CEO of U.S. Physiatry, a physician services company focused on physical medicine and rehabilitation in the post-acute continuum.
Paul has also served in various leadership positions for U.S. Oncology (now McKesson Specialty Health), including leading the oncology specialty pharmacy, drug distribution, radiation and imaging, and other business lines for the Company.
Paul holds a Bachelor of Science in Industrial Engineering from Georgia Tech and a Masters in Business Administration from Emory University.
VP Specialty Solutions TechnologytSonexus
Vice President, Federal Government Relations and U.S. Public PolicyWalgreens
Assistant Professor of Pharmacy Practice, Acute CareDrake University College of Pharmacy and Health Sciences
Healthcare ConsultantBAR Consulting
Specialty PharmacistVanderbilt Specialty Pharmacy
Tara Kelley, PharmD is a graduate of the University of Tennessee College of Pharmacy in Memphis, TN. After graduation she worked in retail pharmacy for three years prior to completing a PGY-1 pharmacy practice residency at University of Tennessee Medical Center in Knoxville, TN. Since joining the Vanderbilt Specialty Pharmacy team, Tara has worked with many disease states, including multiple sclerosis/general neurology, lipid disorders, dermatology, pulmonary hypertension, idiopathic pulmonary fibrosis, and allergy/asthma. She helped to initiate specialty pharmacy services in several different clinics and recently accepted the Clinical Pharmacy Manager position with VSP. She continues to work with multiple clinics, pharmacists and providers to ensure comprehensive and coordinated specialty pharmacy care for Vanderbilt patients. Tara is interested in developing CE topics for specialty medications that are currently available, as well as new specialty medications that are in development.
Principal The Federal Group
Paul T. Kelly is a veteran of the legislative, regulatory and political battles in Washington D.C. Over a 20 year career, he is credited with numerous legislative and regulatory accomplishments on variety of healthcare and business issues. A highly effective advocate and spokesman before Congress, the Executive Branch and the media, he is expert in all aspects of government affairs advocacy and political affairs. He has successfully lobbied in the areas of healthcare reform, Medicare and Medicaid, pharmaceuticals and pharmacy, nutrition and wellness, complementary and alternative medicine, retail and small business, employee benefits, international trade, transportation, criminal justice, electronic payments and more.
Chief Operating OfficerHeritage Biologics
President & FounderPatient Services Inc.
Dana Kuhn, Ph.D., founded Patient Services, Inc. (PSI) 27 years ago. Before the passage of important health care legislation such as the Health Insurance Portability and Accountability Act (HIPAA), the Medicare Modernization Act (MMA), and the Affordable Care Act (ACA), there was PSI. PSI, is a national charity created out of Dr. Kuhn’s personal and professional passion to provide treatment access and affordability to patients and families living with rare and chronic illnesses. Living with an expensive chronic illness himself and experiencing the death of his spouse who was unable to access a life-saving drug, motivated him to create PSI. By providing premium and copayment assistance, PSI allows patients and families to access and afford treatments avoiding financial devastation, bankruptcies, and unnecessary hospitalizations. PSI has helped over 100,000 patients experience better health and financial outcomes throughout the years. His innovation provides opportunities for Specialty Pharmacies to offer patients solutions.
Pediatric PharmacistUniversity of Kentucky
Dr. Robert Kuhn is a specialist in pediatric pharmacy and has been with the College of Pharmacy since 1985. He received a bachelor of arts degree in philosophy from the University of Steubenville (Ohio) and bachelor of science degree in pharmacy from The Ohio State University. His doctor of pharmacy degree was obtained in 1984 from the University of Texas at Austin.
Dr. Kuhn has been an invited speaker at the North American and European Cystic Fibrosis Conference, Cystic Fibrosis Foundation, and National Cystic Fibrosis Caretakers Conference, among many others. He was the recipient of a fellowship from the American Society of Hospital Pharmacists Pediatric Pharmacotherapy and has served as a reviewer for the journals Clinical Pharmacy, Drug Intelligence and Clinical Pharmacy and American Journal of Hospital Pharmacy, and editor of the Kentucky Society of Hospital Pharmacists newsletter.
Vice President, PharmacyBlueCross BlueShield of Michigan
Manager, Education & TrainingDiplomat
Stephanie L. LaPointe is the Manager, Education + Training at Diplomat, where she also fulfills responsibilities as residency coordinator. LaPointe completed a postgraduate year one (PGY1) pharmacy practice residency with a focus in specialty pharmacy at Diplomat in 2012. During her residency, she obtained a teaching certificate though Ferris State University’s Pharmacy Education Development and Lecture Series. She currently acts as adjunct faculty for various colleges of pharmacy across the country and is a Co-Course Coordinator of a Specialty Pharmacy Elective at the University of Michigan. On a national level, LaPointe serves on the National Association of Specialty Pharmacy’s Education Committee, where she acts as Co-Chair of the Student Education Subcommittee. LaPointe is currently serving as the Chair of the Michigan Pharmacists Association’s New Practitioner’s Committee and Chairperson of the Genesee County Pharmacists Association.
PresidentNational Pharmaceutical Council (NPC)
Vice President, Industry RelationsQuintilesIMS
Associate ProfessorSouth Carolina College of Pharmacy
Sr. Director of Health & WellnessSam's Club
Vice President, Clinical/Quality Services and Trade RelationsReCept Pharmacy
Vice President, PharmacyHighmark
Katrina Maggi, PharmD, CSP is a graduate of the University of Tennessee College of Pharmacy in Memphis, Tennessee. Upon joining the Vanderbilt Specialty Pharmacy team, Katrina focused her time in providing specialty pharmacy services at the Vanderbilt Rheumatology clinic where she continues to serve patients and manage their specialty pharmacy needs. As a pharmacist embedded in the clinic, Katrina has a unique opportunity to provide comprehensive and coordinated specialty pharmacy care for Vanderbilt patients. Katrina is interested in developing CE for any topics related to Rheumatology and other inflammatory disease states.
Director, Global Health Economics and Reimbursement StrategyCSL Behring
Rajiv Mallick, PhD, is Director of Global Health Economics and Reimbursement Strategy at CSL Behring and is primarily responsible for the immunoglobulin (IG) therapeutic area. Dr. Mallick has served in the pharmaceutical industry for about 19 years and has extensive experience and abiding interest in health economics, database studies, and patient-reported outcomes. He has published over 50 peer-reviewed manuscripts and presented scientific research findings at over 150 professional meetings. In recent years, Dr. Mallick has presented workshops on varied issues such as (a) a performance based risk sharing model (b) application of the National Institute of Health Patient Reported Outcomes Measurement Information System (NIH-PROMIS) scales to drug/device clinical and other studies and (c) utilizing economic modeling for drug/device pricing strategy, at recent annual meetings of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). In addition to ISPOR, where he also serves on key special interest groups and committees, Dr. Mallick is active on the International Society of Quality of Life (ISOQOL) where he has presented research in the past, and is scheduled to do so again this year.
Dr. Mallick received his doctorate from the State University of New York, Binghamton NY, and prior to joining the life sciences industry, served in consulting as well as academic research roles. He lives in Collegeville PA with his family and is excited to be part of the CSL Behring team in demonstrating value of its unique plasma protein-based therapies in improving lives of patients in key disease areas.
Vice President, PharmacyUPMC Health Plan
With more than 20 years in the specialty pharmacy arena, Dino Martino, R.Ph., has held several senior leadership roles in the specialty pharmacy industry, ranging from pharmacy supervision and design during the growth of one of the first large-scale specialty pharmacies in the 1990s, to ensuring regulatory pharmacy practice and operations responsibility, acting as Pharmacist-in-Charge for one of the nation’s largest specialty pharmacies. From 2010 to 2014 he participated in the design and build of specialty pharmacies for various partners in ranging from health systems, PBMs and even a manufacturer. In 2014, he joined PerformSpecialty as Executive Director and General Manager.
Martino holds a bachelor’s degree in pharmacy from Duquesne University in Pittsburgh, Pennsylvania. He has obtained multiple accreditations for specialty pharmacies including URAC, ACHC, HQAA and JCAHO, and has served as a key information and operations systems consultant in major departments. Martino holds pharmacist licensure in multiple states.
Assistant Professor of NeurologyHarvard Medical School
Paul G. Mathew, MD, FAAN, FAHS is an Assistant Professor of Neurology at Harvard Medical School (HMS), and holds clinical positions at three HMS affiliated institutions. He serves as the Director of Continuing Medical Education at the Brigham & Women's Hospital, Department of Neurology, John R. Graham Headache Center. He is also a staff neurologist at Harvard Vanguard Medical Associates/Atrius Health and the Cambridge Health Alliance. He completed his neurology residency at Temple University Hospital in Philadelphia, PA, and then completed a fellowship in headache medicine at Mayo Clinic in Rochester, MN. He is board certified in neurology and headache medicine. In addition to conventional headache treatments, Dr. Mathew performs Botox injections, trigger point injections, and nerve blocks.
In terms of his academic responsibilities, he has been involved in the training of countless neurology, psychiatry, internal medicine, family medicine, and dental residents, as well as two headache medicine fellows per year. Regarding medical student education, he is the founder and clerkship director of the Harvard Medical School Advanced Neurology Clerkship. He also serves on the faculty of the Harvard Medical School Cambridge Integrated Clerkship.
He has written multiple publications, and has presented at both national and international conferences. Dr. Mathew serves as a peer reviewer for multiple journals including Cephalalgia, Headache, Headache Currents, Mayo Clinic Proceedings, Neurology, the British Medical Journal, and the New England Journal of Medicine. He is the Co-Chief Medical Editor of the journal Practical Neurology. In addition, Dr. Mathew applies his passion for writing as an author on the Harvard Medical School Health Blog (www.health.harvard.edu/blog/author/pgmathew), which is intended to educate the public on a wide array of subjects in medicine. He is a member of several medical societies including the Massachusetts Neurological Association, the American Academy of Neurology, the American Headache Society, and the International Headache Society.
Dr. Mathew also applies his passion and expertise to the role of advocate for both patients and fellow physicians. He has participated in multiple successful lobbying efforts in Washington, DC headed by the American Academy of Neurology to improve patients’ access to healthcare.
Sr. Project Manager, Industrial EngineerSensitech Inc.
As the Sensitech Professional Services Senior Project Manager and Industrial Engineer, Mark is responsible for working with a cross functional team of nine Project and Assistant Project Managers with backgrounds in Industrial Engineering, Packaging, Validation, Logistics, Statistics, and Technical Writing. Mark has been with Sensitech for eleven years.
The team focuses on defining and executing projects such as Storage Validations and Transportation Qualifications, along with Thermal Mappings, Shipping Studies, Risk Controlled Ambient Temperature Profiles, Package Qualifications, Cold Chain Assessments, Gap Analysis, and Continuous Process Improvement through ongoing monitoring. These cold chain visibility solutions enable Sensitech customers to make decisions that meet regulatory and accreditation requirements, impact product quality and improve profitability.
Mark worked previously at United Parcel Service for sixteen years as an Industrial Engineering and Operations Manager. While at UPS, Mark completed numerous projects as a Project Manager focused on supply chain and warehousing improvements.
Mark earned his Master’s in Industrial Engineering and Bachelors in Architecture from the University at Buffalo.
Vice President, Pharmacy Operations Virginia Premier Health Plan
Javier earned his Bachelor of Science in Pharmacy from Long Island University; and his MBA from Virginia Commonwealth University. He is Board Certified in Geriatric Pharmacy and currently serves as the Vice President for Pharmacy Operations for Virginia Premier Health Plan, Inc. Javier has worked in managed care pharmacy and Medicaid for over 12 years and has a strong clinical, administrative and management background in the pharmacy and PBM areas of managed care. He is active in a variety of professional activities and is a board member of Commonwealth Community Trust; a nonprofit organization that administers special needs trust for people with disabilities and United Way’s Health Action Council of the greater Richmond and Petersburg area. In addition, Javier serves as adjunct faculty for the School of Pharmacy at Virginia Commonwealth University as a preceptor for managed care pharmacy.
Sr. Vice President of Product Innovation, Marketing and Advanced AnalyticsMagellan Rx Management
Matthew is the Senior Vice President of Product Innovation, Marketing and Advanced Analytics. He leads MRx Studio, an autonomous group that is focused on exploring, designing, and building ideas and solutions that foster innovation and help MRx members live more vibrant lives. Additionally, he is responsible for Marketing where he steers the company’s positioning, messaging and creative execution across a variety of channels, Advanced Analytics, where he oversees the strategic direction and implementation of the organization’s richly visualized, powerful analytic tools that help clients turn data into knowledge. Before joining MRx, he was a management consultant for Cap Gemini Ernst & Young where his responsibilities included identifying, planning, and executing information technology driven business strategies for healthcare companies.
Matthew earned a Master of Business Administration with Honors from the University of Chicago, Booth School of Business, and his Bachelor of Science in Business Administration from the University of Arizona where he graduated Magna Cum Laude with University Honors.
Sr. Director, Specialty Clinical ServicesWalgreens
PartnerHolland & Knight, LLP
Jeffrey W. Mittleman is a partner of the law firm Holland & Knight and Co-leader of the firm's Healthcare & Life Sciences Industry Team. He practices in the areas of health, regulatory and corporate law. With more than 15 years of experience, Jeff represents clients in a variety of sectors, including; specialty pharmacies, pharmacy benefit managers, pharmaceutical and device manufacturers, retail, compounding and long-term care pharmacies and wholesale distributors. Jeff counsels clients in a variety of corporate and contractual transactions and advises clients in fraud and abuse counseling and defense, structuring compliance and ethics programs, Medicare and Medicaid and managed care law. Jeff earned his law degree from American University.
Chief Operations OfficerBioPlus Specialty Pharmacy
Sr. Vice President, Government AffairsAmerisourceBergen
Rita Norton opened the AmerisourceBergen (ABC) Washington, D.C. Government Affairs office in October 2004 as Senior VP Government Affairs & Public Policy. She directs the State and Federal lobbying efforts of the Valley Forge, PA based pharmaceutical distribution services company.
Prior to joining ABC, Ms. Norton served as Vice President of Government Relations for Amgen from 1997 to July 2004, overseeing State and Federal Government Relations. From 1992 to 1997 she led Government Affairs for Hoffman LaRoche. Ms. Norton began her career in Washington, DC working for U.S. Senator Robert W. Kasten (R-WI), and then the Senate Appropriations Committee for Chairman Mark O. Hatfield (R-OR) from 1981 to 1987.
Ms. Norton holds a BA in Communications and Political Science from Marquette University, Milwaukee, WI and pursued graduate studies at Georgetown University and the University of Southern California. In addition, Ms. Norton serves on the Board of Directors of the Children’s Charities Foundation and the Ripon Society.
Principal & Chief Operating OfficerCurant Health
Marc O'Connor is a principal owner and Chief Operating Officer/ Chief Strategy Officer for Curant Health. Curant Health is a national healthcare company focusing on improving the outcomes and lives of chronic disease state patients. Curant Health is one of the fastest growing health care companies in the nation including being one of only four large health care companies to be on the INC 500/5000 for four straight years.
Marc has twenty five years of C-Level executive management, finance, and business development experience in the health care, energy, commercial construction, and energy infrastructure industries around the country. Before Curant Health, Marc was the President and Founder of Maxon Holdings, a large scale national energy development company which was acquired by a global multinational energy firm. He brings his strategy and implementation expertise to expand Curant Health’s reach and services to ensure improved outcomes for chronic disease state patients around the nation.
In 2007, Marc was named to the Catalyst's Top 25 Entrepreneurs and Ones to Watch list. Released each year, Catalyst's Top 25 Entrepreneurs recognizes those who are leading Atlanta's business community. Marc could also be seen on the Discovery Channel’s “Greensburg” television program related to the development of the Greensburg, KS Energy Master Plan and Wind Farm project. Marc has also been published in numerous periodicals and most recently in Specialty Pharmacy Times, Managed Healthcare Executive, MedCity News, and Fierce Health.
Marc is currently on the Board of Directors for the Georgia Chamber of Commerce as well as the international diabetes advocacy charity Team Type 1. Marc is also on the Board of Directors for the American Heart Association Heart Ball which is the Georgia American Heart Association’s largest fund raising event.
Vice President, Business OperationsPANTHERx Specialty Pharmacy
Executive Vice President, Manufacturer RelationsAsembia
Divisional Vice President, Digital HealthWalgreens
Greg is an enthusiastic, results-driven executive with a passion for driving change in healthcare by engaging consumers to improve their health. He has over 15 years of experience in product strategy, technology, product design/delivery, and bringing successful products to market.
His digital health career began in 2000 with the design, creation and deployment of the world’s first consumer oriented online symptom checker. He has assisted multiple Fortune 500 companies in executing consumer health engagement strategies to improve the health and wellbeing of their constituents.
He joined Walgreens in 2014 to lead product strategy and execution for the Digital Health division. His responsibilities have included digital adherence, consumer engagement and discovering new ways to promote healthy choices for Walgreens customers. He also works closely with partners including payers, health systems, pharmaceutical companies and employers to find synergies that benefit mutual customers.
In September of 2016, he became Divisional Vice President of Digital Health and now oversees all aspects of digital health under the Health Innovation Platform for the broader Walgreens Boots Alliance organization.
Pharmacy Patient Medication Principal CoordinatorEmily Couric Clinical Cancer Center
Senior Vice President, Clinical OperationsAsembia
Arpan Patel is the Senior Vice President of Clinical Operations at Armada Health Care. Prior to this role, Arpan served as Senior Director of Pharmacy Operations for Accredo/ Curascript/Freedom Specialty Pharmacy (Medco/Express Scripts). Before this role, Arpan served as Director of Compliance at Curascript Specialty Pharmacy since 2011.
Arpan began his career at CVS Pharmacy as a staff pharmacist, later moving into Specialty Pharmacy with Schraft’s Specialty Pharmacy as a staff pharmacist and then Walgreens Specialty Pharmacy as General Manager. He previously served on the Board of the Delaware Pharmacist Society.
Arpan received a master’s of business administration in healthcare administration from the New York Institute of Technology and a bachelor’s degree in pharmacy from Northeastern University.
Vice President, Clinical OperationsAsembia
Shivani Patel is the Vice President of Clinical Operations at Asembia. Prior to this role, Shivani served as a Director of Pharmacy for QPharmacy managing pharmacy operations and business development. Before this role, Shivani served as a Clinical Specialty Pharmacist Team Lead at CVS Health since 2007, where she managed their Compliance & Persistency program.
Shivani began her career at Stop & Shop pharmacy as a staff pharmacist after receiving her PharmD from Rutgers University Ernest Mario School of Pharmacy in 2006.
Assistant director of Pharmacy - Clinical ServicesAids Healthcare Foundation
Director, Equity Research, Pharma Supply Chain and HICTBarclays
Assistant ProfessorDuke University Medical Center
Vice President, Specialty Pharmacy and Industry Relationsu5OptumRx
Vice President, US Government RelationsPfizer
Principal & Consulting ActuaryMilliman
Kelly Ratliff, DPh, serves as President of US Bioservices, a national specialty pharmacy, where she has held a number of leadership positions during her 20-year tenure, including COO, VP of Operations and Director of Pharmacy Operations. Dr. Ratliff’s expertise includes pharmacy operations, clinical services, payer strategy, commercial activities and business development.
Vice President, Medical Pharmacy StrategyMagellan Rx Management
Joe has over 30 years of financial, human capital and operational management experience collectively. He is the Market Leader for both the Cloud Solutions & Management Consulting practice and Cyber & Information Security Services practice and a certified public accountant. Joe is a proven, results drive, entrepreneurial professional focused on improving the financial, human capital and operational management activities for companies across a variety of industries. He specialized in managing programs, leading change enablement and enterprise transformation programs, and he has a recognized ability to leverage people, process, technology and information to drive performance and deliver key business objectives with tangible results.
A graduate of Fairleigh Dickinson University with a degree in accounting, Joe is a certified public accountant in the states of New Jersey and New York. He is a member of the New Jersey Society of Certified Public Accountants (NJCPA) and the New York State Society of CPAs (NYSSCPA). Joe resides in Hunterdon County, NJ.
Executive Vice President, OperationsDiplomat
Gary became Diplomat’s executive vice president of operations in 2016. He is responsible for Diplomat’s core operational management. This builds on his previous role as senior vice president of Clinical, Education, and Human Resources, in which he was responsible for Diplomat’s industry-leading clinical support services; education for patients and clients; and Human Resources department.
Before joining Diplomat in June 2011, Gary was vice president of operations at ITSRx, where he provided operational and clinical leadership for the development of specialty and retail pharmacies. Gary also served as director of specialty clinical management for MedImpact Healthcare Systems Inc. He directed oncology strategy, specialty pharmacy sales management, the clinical guidance of specialty medication providers, and the clinical protocol development of 15 specialty therapy categories. Before his time at MedImpact, he was vice president of retail and ancillary services and director of pharmaceutical services at the Kelsey-Seybold Clinic in Houston, Texas.
Gary graduated with a Bachelor of Science in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences in Boston. He also earned his Master of Science in pharmacy from the University of Houston and completed his Master of Business Administration from the University of Phoenix.
Principal, Global Market Access & PricingSkysis
Vice PresidentOptum Life Sciences
Assistance Vice President, Business Development – Pharmacy ServicesCarolinas HealthCare System
Founding PartnerBlue Fin Group
Bill is an expert in connecting healthcare products to patient populations. He is a proven innovator on a broad range of disciplines in the healthcare industry including product and channel strategy, program development, data analytics, brand protection, organizational design, process optimization, policy creation and compliance, strategic marketing, customer service and the assessment and the design of technology. He has been publicized in over 25 industry publications, is frequently cited by market researchers and analysts for his accurate predictions of future events, and speaks frequently at industry events and seminars on subject of healthcare commerce related issues.
Tim Safley has more than three decades of experience in the health care profession, including twenty-five years in the pharmacy industry. Tim was the Regional Vice President for a national home care company and his leadership includes the HME, infusion & specialty markets. He was instrumental in helping add specialty requirements to the ACHC pharmacy program in early 2001. As this industry evolved he was also able to adapt these requirements to address payer needs to help meet the ever changing requirements of this health care sector. Tim has a great track record of working with payers and PBM’s to help tackle the need for both patient monitoring and cost containment within the specialty industry. He led the initiative to release the accreditation in Oncology Distinction program at ACHC, and is constantly working to address the needs of ACHC accredited pharmacies. . He serves on several national boards and is an authority is preparing companies for federal, state and accreditation site visits.
President & CEONational Organization of Rare Disorders
Senior Vice President, Commercial ConsultingXcenda
Matt Sarnes, PharmD, is Senior Vice President of the Commercial Consulting practice at Xcenda, which focuses on helping manufacturers develop innovative strategies and tactics to overcome barriers to product access. He has over 15 years of experience across several disciplines, including market access, health economics, reimbursement, quality improvement, marketing, and distribution strategy. Dr. Sarnes received his Doctor of Pharmacy from the University of Pittsburgh. He received his post-doctoral training in Ambulatory Care and Outcomes Research from Healthcore, Inc. and the Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia.
General Manager, US BiosimilarsPfizer
General Session Keynote Speaker
Mike has over 20 years of experience in marketing and sales, market access, channel design, sales training and sales management, and has been involved in over 22 product launches in sales, marketing or consulting roles. He has held leadership positions with global companies such as Johnson & Johnson, UCB and United BioSource Corporation.
With expertise in design and execution of access strategies, Mike has launched more than 40 patient and provider support programs encompassing diverse issues such as reimbursement, channel design, patient assistance programs, copay programs, call centers, sites of care and clinical trial support. His core areas of experience include products with complex characteristics such as high cost oral, IV, SC and IM therapies.
Mike earned a BA in Marketing from Northeast Louisiana University.
Associate ProfessorPurdue University College of Pharmacy
Senior Project Leader and Senior ResearcherHarvard Business School
Mahek Shah, MD is a Senior Project Leader and Senior Researcher at Harvard Business School. Working with Professors Robert S. Kaplan and Michael E. Porter, he designs and implements a new framework for restructuring health care systems around the world, Value-Based Health Care, with the overarching goal of delivering more value for the patient: better outcomes at lower costs. He leads Harvard Business School Value Measurement in Health Care projects, implementing time-driven activity-based costing (TDABC) to understand true costs of care delivery.
For more than 10 years, Dr. Shah has focused on redesigning health care to improve patient outcomes, the experience, and leverage technology. His methodologies emphasize human-centered design that is real-time and data-driven. Shah speaks globally on the future of care delivery, design thinking, and the business of healthcare.
Dr. Shah has served corporations, world-renowned health care systems, and venture-backed companies through his own consulting practice. He has contributed to Forbes and delivered a TEDx talk at Harvard: Bringing Patient-centered Design to Healthcare.
He served on the Office of National Coordinator (ONC) review panel for the US Department of Health and Human Services (HHS) and is an adviser to the French Tech Hub, France’s largest accelerator in the US. Prior to medicine, Dr. Shah worked on Wall Street at Citigroup.
Dr. Shah received his medical degree from Baylor College of Medicine and undergraduate degrees in Economics and Religious Studies cum laude from Rice University. He’s a competitive tennis player and a proud twin. Shah stays very active on twitter at @Mahek_MD
Chief Executive OfficerAvella Specialty Pharmacy
As Chief Executive Officer, Ms. Shanahan brings extensive healthcare and specialty pharmacy experience to Avella Specialty Pharmacy. She is responsible for overseeing the organization’s operations and growth strategies, transforming Avella into the leading national omni-channel provider of specialty and compounded medications. Ms. Shanahan also currently serves as the President of the National Association of Specialty Pharmacy (NASP). In this capacity, she leads the efforts to advocate for its member pharmacies and educate stakeholders including regulators, media and other health care organizations on their behalf. In fact, Inc. Magazine named Ms. Shanahan as the Top Woman Entrepreneur in America in 2015.
Ms. Shanahan earned her Juris Doctor from the Indiana University School of Law at Bloomington and is admitted to practice law in Indiana and Illinois
Professor of Medicine, Pediatrics, and Psychology University of Miami
Professor of Neurology, DirectorJefferson Headache Center, Thomas Jefferson University
Chief Medical OfficerOptum Life Sciences
Brian Solow, MD, FAAFP currently serves as the chief medical officer for Optum Life Sciences, a segment of Optum and UnitedHealth Group. Optum Life Sciences helps pharmaceutical, biotechnology and medical device companies successfully address product development and commercialization challenges by delivering a full range of integrated solutions in the areas of strategic insight, value assessment, evidence development, alignment to commercial needs and launch support. Prior to his current position, Dr. Solow served as the Chief Medical Officer for OptumRx which provides innovative pharmacy benefit management (PBM) services and products to employer groups, union trusts, commercial, Medicare and other governmental health plans. Dr. Solow’s primary responsibility there was the coordination of clinical activities related to the development, enhancement and implementation of clinical programs supporting formulary management for OptumRx clients.
Prior to joining the clinical team at Optum, Dr. Solow was an active member of a physician-owned medical group, maintaining a full-time practice while simultaneously holding various management roles within the group. He has served as a member of national pharmacy and therapeutics committees for leading managed care organizations and pharmacy benefit management firms. Dr Solow is a well-known National and International speaker on a variety of topics relating to Pharmacy management.
Dr. Solow holds an active appointment as clinical professor at the University of California, San Francisco, School of Pharmacy, and an appointment at the University Of Southern California School Of Pharmacy. He received the Family Medicine department award from the University of California, Irvine School of Medicine for distinguished practice and teaching.
Dr. Solow is a fellow of the American Academy of Family Physicians, a member of the U.S. Pharmacopeia (USP) Medicare Model Guideline Expert Panel advisory committee, as well as serving on FDA advisory panels. He is also active in ISPOR-serving as the U.S. representative for the Health Technology Assessment Council. The Orange County Medical Association has recognized him several times as a Physician of Excellence.
EVP, Clinical Affairs & Quality AssuranceAvella Specialty Pharmacy
Dr. Eric Sredzinski is responsible for the Clinical Management, Disease State Management, training, and implementation of patient adherence and persistence programs for Avella Specialty Pharmacy. Working closely with the company’s Oncology, Infectious Disease, and Transplant teams for presentations and business development, Dr. Sredzinski, a member of Avella Specialty Pharmacy’s top management since joining the company in 2001, is also responsible for the management of manufacturer contracted data sets, including the participation in the development and testing of the data layout. Graduating with a Doctor of Pharmacy degree from the University of Arizona College of Pharmacy (2000), Dr. Sredzinski focused his training in oncology/infectious disease.
Editor-In-ChiefSpecialty Pharmacy Times
Co-Founder & CEOAdhereTech
Vice President, ComplianceElwyn Pharmacy Group
Associate Director, Clinical ServicesJohns Hopkins Outpatient Pharmacy
Meghan Swarthout is the Division Director of Ambulatory and Care Transitions for the Department of Pharmacy at The Johns Hopkins Hospital and the Associate Director of Clinical Services for Johns Hopkins Outpatient Pharmacy.
Meghan earned her Doctorate of Pharmacy from Ohio Northern University. Following completion of her PharmD, Meghan completed her PGY1 and PGY2 in Health System Pharmacy Administration at The Johns Hopkins Hospital while also completing her MBA in Medical Services Management at Johns Hopkins University.
Meghan is responsible for ambulatory care clinical services, population health, and transitions of care infrastructure for The Johns Hopkins Health System. She oversees drug distribution for ambulatory infusion clinics and leads clinical services Johns Hopkins Outpatient Pharmacy. She maintains a clinical practice in anticoagulation clinic. She led the team that redesigned the interdisciplinary transitions of care model for Johns Hopkins Health System, and her team was a recipient of the ASHP-APhA Medication Management in Care Transitions Best Practices Award.
Meghan is the Immediate Past President of the Maryland Society of Health System Pharmacy and Chair of the ASHP Council on Education and Workforce Development.
Divisional Vice President, Specialty Pharmacy Development & Brand Rx/Vaccine PurchasingWalgreens
As Divisional Vice President, Specialty Pharmacy Development & Brand Rx/Vaccine Purchasing, Ray Tancredi oversees a team responsible for all specialty pharmacy trade functions including Specialty Pharmacy product access and relationships, managing manufacturer hub services and referrals, contract negotiation, implementation and compliance, pharma programs and services, data analysis and reporting, RFP support and coordinating clinical, patient services, new drug in-services, and education. Additionally, Ray oversees management of strategic manufacturer accounts in an effort of maximize contracts and provide exceptional customer service.
Ray earned his Bachelor of Science in Pharmacy from Temple University School of Pharmacy (1983) and is a registered pharmacist in good standing. He also holds a Master of Business Administration in Management from Eastern University (2001).
Director & Managing Counsel, Pharmacy Purchasing & Development LegalWalgreens
Senior Director, Outpatient Pharmacy ServicesJohns Hopkins Home Care Group
PrincipalThe McManus Group
Vice President, Managed Care & ContractingBioPlus Specialty Pharmacy
Luis Torres is the Vice President of Managed Care for BioPlus Specialty Pharmacy. In his role, Luis is responsible for serving as a strategic partner to Health Plans, PBMs, Employers and Consultants in order to bring comprehensive solutions to BioPlus clients. Luis is also responsible for managed care pricing, contracting, strategic initiatives and business development for the organization. Prior to joining BioPlus Luis held executive positions at Walgreens and Amber Pharmacy. Luis holds a BS and MBA Degree from Nova Southeastern University.
President & CEOEtectRx
Mr. Travis is currently the President and CEO of etectRx, Inc. etectRx has developed a novel wireless system that incorporates a tiny ingestible wireless transmitter/receiver into capsules to definitively, reliably, and safely indicate when a patient has taken their medicine
Mr. Travis is an experienced senior executive with over 25 years experience in all aspects of pharmaceutical distribution channel management. He has held senior leadership positions with Baxter Healthcare, Cardinal Health, Accredo/Medco and Aetna. Most recently he held the position of Vice President of Aetna’s Specialty and Home-Delivery Pharmacy Business.
Harry holds a BS in Pharmacy from the University of Pittsburgh, School of Pharmacy, and an MBA from The Darden School at the University of Virginia.
Chairman & CEOPANTHERx Specialty Pharmacy
Chief Pharmacy & Growth OfficerAlliance Rx Walgreens Prime
Don Vidic is the Chief Pharmacy and Growth Officer for AllianceRx Walgreens Prime, a combined central specialty pharmacy and mail services company formed by Walgreens and Prime as part of a strategic alliance first announced by the companies last August. Don is responsible for pharmacy product development, pharmacy services, sales support and professional practice and accreditation services for the new venture. He joined Walgreens Specialty Pharmacy in December 2008 and has held various roles over the past few years including Division Vice President of Specialty Strategy and Vice President of Operations and Pharmacy Services.
Immediately prior to joining Walgreens, Don was Vice President and General Manager of McKesson Specialty pharmacy. Don began his tenure with McKesson as Vice President of Operations.
Adding to his more than 24 years of Specialty Pharmacy experience, Don spent four years as Senior Director of Operations for Medco Specialty Services. He built the first dedicated Specialty Operation for Medco and was ultimately responsible for the Accredo joint operations partnership until their acquisition.
Don received his B.S. in pharmacy from the University of Pittsburgh and his Masters in Business Administration from Waynesburg University.
Director, Digital Business & Marketing StrategyHumana
Nick Walter is Director of Digital Strategy, Marketing, and Innovation for Pharmacy and Provider at Humana, where he leads a team of over 30 consisting of strategists, marketers, interaction designers, and product owners focused on developing new digital experiences to increase adoption and engagement of digital products. In his 9 years at Humana, he has held numerous leadership roles overseeing Web and mobile development, including the successful launch of a responsive ecommerce site and mobile app that has enabled digital pharmacy orders to double year over year. Nick aims to improve the customer journey and health outcomes by leveraging new technology and employing unique marketing strategies such as funnel optimization and multi-variant testing to convert and retain digital customers.
Sr. Vice President, Specialty Pharmacy OptumRx
Senior Director of Pharmacy - Systems DevelopmentAids Healthcare Foundation
Managing PartnerUpstream, a Biopharma Partners Company
Receive the most current information from the Summit & Asembia.